Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | hace 568
Stocktwits
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

Tags: PLX
Stocktwits
read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | hace 768
Japan Shares May Be Stuck In Neutral On Thursday

Japan Shares May Be Stuck In Neutral On Thursday

The Japanese stock market has moved higher in back-to-back sessions, collecting almost 110 points or 0.3 percent along the way. The Nikkei 225 now rests just above the 35,725-point plateau although the rally may stall on Thursday.
RTTNews | hace 4h 31min
Exporters Likely To Weigh On South Korea Shares

Exporters Likely To Weigh On South Korea Shares

The South Korea stock market headed south again on Wednesday, one day after ending the three-day losing streak in which it had stumbled more than 160 points or 6.4 percent. The KOSPI now rests just above the 2,500-point plateau and it may take further damage on Thursday.
RTTNews | hace 5h 1min
Australia Trade Data Due On Thursday

Australia Trade Data Due On Thursday

Australia will on Thursday release February figures for imports, exports and trade balance, highlighting a modest day for Asia-Pacific economic activity.
RTTNews | hace 6h 1min
Trump Announces Sweeping Reciprocal Tariff Plan

Trump Announces Sweeping Reciprocal Tariff Plan

President Donald Trump delivered a highly anticipated speech from the White House Rose Garden on Wednesday outlining his plan to impose sweeping tariffs on U.S. trade partners. Trump's plan purportedly calls for a baseline 10 percent tariff to be imposed on all U.S. imports except those compliant with the United States-Mexico-Canada Agreement. Certain countries will face much higher tariffs.
RTTNews | hace 6h 28min
Herramientas
Calendario económico
Market Hours
Interest Rates
Holidays Calendar
Mercados Forex
Volatilidad Forex
Correlación Forex
Noticias del Forex
forex analysis
Datos COT
Liquidez
Calculadoras Forex
Heat Map del Forex
Indicators Heatmap
Comunidad
Comunidad
Sistemas
Sistemas más populares
Estrategias
Concursos
Gráficos Forex
Sentimiento Forex
Indicador de perspectivas
Revisiones
Corredores de bolsa
Prop Trading Firms
Servicios SPV
Proveedor de señales
Servicios de programación de AE
Affiliate Programs
Servicios de corretaje PAMM
Servicios de programas de rebaja
Plataformas de trading
Asesores Expertos
Exchanges de Criptomonedas
Trading Courses
Corredores de bolsa
Spreads de Forex
Cotizaciones de los corredores de Forex
Swaps de corredores de Forex
Volumen del corredor Forex
Promociones de corredores Forex Press Release
Plataforma
Widgets
Funciones
API
RSS
Stock Portfolio
Affiliate Software
Gráficos avanzados
Soporte
FAQ
Ayuda
Póngase en contacto con nosotros
¡Informar de un error!
Acerca de
Blog
© 2025 Myfxbook Ltd. Todos los Derechos Reservados.
ADVERTENCIA DE ALTO RIESGO: El comercio de divisas implica un alto nivel de riesgo que puede no ser adecuado para todos los inversores. El efecto de apalancamiento crea un riesgo adicional y una exposición a las pérdidas. Antes de decidirse a operar con divisas, considere cuidadosamente sus objetivos de inversión, su nivel de experiencia y su tolerancia al riesgo. Podría perder una parte o la totalidad de su inversión inicial. No invierta dinero que no puede permitirse perder. Infórmese sobre los riesgos asociados al trading de divisas y pida consejo a un asesor financiero o fiscal independiente si tiene alguna duda. Todos los datos y la información se proporcionan "tal cual" con fines informativos únicamente y no están destinados a fines comerciales o de recomendación. Los resultados pasados no son indicativos de los resultados futuros.